Gerard Berry
Physician · Boston Children's Hospital
Credentials: · · · ·
History
2019–Present
- 1975–1977
Medical Genetics and Genomics
Research
Survival after treatment with phenylacetate and benzoate for urea-cycle disorders
New England Journal of Medicine · 2007 · 270 citations
Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders
American journal of medical genetics. Part B · 2010 · 232 citations
Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
Kidney International · 2014 · 199 citations
- SS
30 papers
19 papers
16 papers · 12 as a resident
- PK
13 papers
10 papers
10 papers
9 papers
- LE
9 papers
Grants
- 2022–2027
Society for Inherited Metabolic Disorders Annual Meeting
National Institute of Child Health and Human Development · R13
Contact PI · $40K · Boston Children's Hospital
- 2019–2026
Hyperphenylalaninemia Disorders Consortium of the Rare Disease Clinical Research Network
National Institute of Child Health and Human Development · U54
Project lead · $884.7K · Oregon Health & Science University
- 2024–2026
Optimal Window of Opportunity for Granulosa Cell Gene Therapy in Galactosemia
National Institute of Child Health and Human Development · R21
PI · $425.1K · Utah State Higher Education System--University of Utah
- 1997–2001
Enigma of Galactosemia: Searching for Answers
National Institute of Child Health and Human Development · P01
Project lead · $729.9K · Children's Hosp of Philadelphia